Stonehage Fleming Financial Services Holdings LTD Organon & Co. Transaction History

Stonehage Fleming Financial Services Holdings LTD

$3.57 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$17.45 - $21.96 $610 - $768	-35 Closed	0 $0
Q3 2022 Nov 09, 2022	BUY	$23.4 - $34.25 $819 - $1,198	35 New	35 $0
Q3 2021 Nov 09, 2021	SELL	$28.63 - $35.64 $2,863 - $3,564	-100 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $2,845 - $3,800	100 New	100 $3,000

Others Institutions Holding OGN

# of Institutions

808

Shares Held

201M

Call Options Held

1.53M

Put Options Held

1.07M

Black Rock Inc. New York, NY

32.6M
Shares

$505 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.4M
Shares

$471 Million
0.01% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.2M
Shares

$173 Million
0.41% of portfolio
Massachusetts Financial Services CO Boston, MA

9.9M
Shares

$153 Million
0.05% of portfolio
State Street Corp Boston, MA

9.34M
Shares

$145 Million
0.01% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.94B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.

Account